Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study-Reference-Cited by-同舟云学术

Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study

Published:2018-12 Issue:12 Volume:6 Page:e1386-e1396
ISSN:2214-109X
Container-title:The Lancet Global Health
language:en
Short-container-title:The Lancet Global Health

Author:

Gouglas Dimitrios,Thanh Le Tung,Henderson Klara,Kaloudis Aristidis,Danielsen Trygve,Hammersland Nicholas Caspersen,Robinson James M,Heaton Penny M,Røttingen John-Arne

Publisher

Elsevier BV

Subject

General Medicine

Reference33 articles.

1. The need for global R&D coordination for infectious diseases with epidemic potential;Kieny;Lancet,2016

2. Risk in vaccine research and development quantified;Pronker;PLoS One,2013

3. Establishing a global vaccine-development fund;Plotkin;N Engl J Med,2015

4. New vaccines against epidemic infectious diseases;Røttingen;N Engl J Med,2017

Cited by 216 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The economic case for scaling up health research and development: Lessons from the COVID-19 pandemic;Proceedings of the National Academy of Sciences;2024-06-17

2. Study of different heterocycles showing significant anti-severe acute respiratory syndrome 2 activity in vitro and in vivo;Veterinary World;2024-06

3. Opportunities and challenges for T cell-based influenza vaccines;Nature Reviews Immunology;2024-05-02

4. Realising the potential of correlates of protection for vaccine development, licensure and use: short summary;npj Vaccines;2024-04-29

5. Switched Epidemic Models: A Contact Rate Dependent Analysis;Applied Mathematical Modelling;2024-04